Andromeda Biotech
42 Hayarkon Street
Industrial Area
Yavne
81227
Tel: 972-8-938-7777
Fax: 972-8-940-7737
8 articles about Andromeda Biotech
-
Laborie Medical Technologies Acquires Andromeda
3/9/2017
-
Clal Biotech Opts Out of Re-Acquiring Andromeda from Hyperion After Phase III Diabetes Drug Tanks
10/7/2015
-
Evotec AG Takes Legal Steps Against Andromeda Biotech
9/18/2014
-
Hyperion Therapeutics Completes Acquisition Of Andromeda Biotech
6/12/2014
-
Hyperion Therapeutics Wagers Up To $570 Million On Andromeda Biotech To Beef Up Orphan Disease Pipeline
4/24/2014
-
Andromeda Biotech Acquires DiaPep277 Rights From Teva Pharmaceutical Industries Limited
2/24/2014
-
Andromeda Biotech Announces The Acceptance Of Two Manuscripts For Publication Describing Its Phase 3 DIA-AID 1 Study
1/13/2014
-
Andromeda Biotech Announces First Patient Dosed In Extension Study To Its Phase 3 Clinical Trial DIA-AID 2 In Patients With Type 1 Diabetes
12/18/2013